Hirsch EC - Search Results

1

Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?

Hartmann A, Michel PP, Troadec JD, Mouatt-Prigent A, Faucheux BA, Ruberg M, Agid Y, Hirsch EC. Hartmann A, et al. Among authors: hirsch ec. J Neurochem. 2001 Mar;76(6):1785-93. doi: 10.1046/j.1471-4159.2001.00160.x. J Neurochem. 2001. PMID: 11259496 Free article.

2

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

Kastner A, Hirsch EC, Lejeune O, Javoy-Agid F, Rascol O, Agid Y. Kastner A, et al. Among authors: hirsch ec. J Neurochem. 1992 Sep;59(3):1080-9. doi: 10.1111/j.1471-4159.1992.tb08350.x. J Neurochem. 1992. PMID: 1494900

3

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.

Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y. Hirsch EC, et al. J Neurochem. 1991 Feb;56(2):446-51. doi: 10.1111/j.1471-4159.1991.tb08170.x. J Neurochem. 1991. PMID: 1988548

4

Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease.

Hirsch EC, Graybiel AM, Agid Y. Hirsch EC, et al. Acta Neurol Scand Suppl. 1989;126:19-22. doi: 10.1111/j.1600-0404.1989.tb01778.x. Acta Neurol Scand Suppl. 1989. PMID: 2575832

5

Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?

Mouatt-Prigent A, Agid Y, Hirsch EC. Mouatt-Prigent A, et al. Among authors: hirsch ec. Brain Res. 1994 Dec 30;668(1-2):62-70. doi: 10.1016/0006-8993(94)90511-8. Brain Res. 1994. PMID: 7704619

6

Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease.

Kastner A, Hirsch EC, Agid Y, Javoy-Agid F. Kastner A, et al. Among authors: hirsch ec. Brain Res. 1993 Mar 26;606(2):341-5. doi: 10.1016/0006-8993(93)91005-d. Brain Res. 1993. PMID: 8098254

7

Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease.

Kastner A, Hirsch EC, Herrero MT, Javoy-Agid F, Agid Y. Kastner A, et al. Among authors: hirsch ec. J Neurochem. 1993 Sep;61(3):1024-34. doi: 10.1111/j.1471-4159.1993.tb03616.x. J Neurochem. 1993. PMID: 8103078

8

Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease.

Faucheux BA, Hirsch EC, Villares J, Selimi F, Mouatt-Prigent A, Javoy-Agid F, Hauw JJ, Agid Y. Faucheux BA, et al. Among authors: hirsch ec. J Neurochem. 1993 Jun;60(6):2338-41. doi: 10.1111/j.1471-4159.1993.tb03527.x. J Neurochem. 1993. PMID: 8492137

9

Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?

Damier P, Kastner A, Agid Y, Hirsch EC. Damier P, et al. Among authors: hirsch ec. Neurology. 1996 May;46(5):1262-9. doi: 10.1212/wnl.46.5.1262. Neurology. 1996. PMID: 8628464

10

Nitric oxide synthase and neuronal vulnerability in Parkinson's disease.

Hunot S, Boissière F, Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, Hirsch EC. Hunot S, et al. Among authors: hirsch ec. Neuroscience. 1996 May;72(2):355-63. doi: 10.1016/0306-4522(95)00578-1. Neuroscience. 1996. PMID: 8737406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters